| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $702K | +246.4% |
| Cost of Revenue | $3.1M | +1035.8% |
| Gross Profit | -$2.4M | -3184.8% |
| R&D Expense | $272K | +170.1% |
| SG&A Expense | $39.6M | +216.3% |
| Interest Expense | $35K | -29.3% |
| Net Income | -$49.4M | -227.6% |
| EPS (Basic) | -$0.91 | -85.7% |
| EPS (Diluted) | -$0.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $55K | -93.5% |
| Accounts Receivable | $84K | +1396.2% |
| Inventory | $234K | -70.7% |
| Current Assets | $2.6M | -66.4% |
| Total Assets | $7.3M | -42.3% |
| Current Liabilities | $9.4M | +162.0% |
| Total Liabilities | $9.5M | +144.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $87K | -17.9% |
| Investing Cash Flow | -$5K | +98.5% |
| Financing Cash Flow | $15.6M | +21.9% |
| -85.7% |
| Stockholders' Equity |
| -$2.2M |
| -124.6% |